Who is sponsoring NCT03070249?

NCT03070249 is sponsored by University of Florida.

What drugs are being tested in NCT03070249?

Interventions in NCT03070249: Professional Quality of Life (ProQoL) scale.

What condition does NCT03070249 study?

NCT03070249 studies Compassion Fatigue.

Is NCT03070249 still recruiting?

NCT03070249 is currently completed. Last updated 24 October 2017.

Last reviewed 2017-10-24 · How we verify

NCT03070249

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compassion Fatigue in ED Providers

Completed Last updated 24 October 2017

What this trial tests

trial testing Professional Quality of Life (ProQoL) scale in Compassion Fatigue in 100 participants. Completed in 10 October 2017.

Timeline

13 April 2017

Primary endpoint
25 April 2017

10 October 2017

Quick facts

Lead sponsor	University of Florida
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	13 April 2017
Primary completion	25 April 2017
Estimated completion	10 October 2017
Sites	1 location across United States

Drugs / interventions tested

Professional Quality of Life (ProQoL) scale

Conditions studied

Compassion Fatigue — all drugs for Compassion Fatigue →

Sponsor

University of Florida

Who can join

18 and older, any sex, with Compassion Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess compassion fatigue among healthcare providers in a single emergency department (ED) using the Professional Quality of Life (ProQoL) scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Compassion Fatigue

Currently open trials in the same condition.

NCT05942469 — Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) · NA · recruiting
NCT05884073 — Exercise for Oncology Care Professionals · NA · recruiting

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03070249 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 24 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03070249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing